Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kontogiorgi, V. Kalodimou, G. Agrogiannis, E. Patsouris, A. Papalois (Pikermi, Amarousion, Athens, Greece). Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury. Eur Respir J 2010; 36: Suppl. 54, 2452

Member's Comments

No comment yet.

Related content which might interest you: Modified mesenchymal stem cells attenuate bleomycin induced lung injury in the rat Source: Annual Congress 2010 - Stem cells and growth factors in lung injury Year: 2010 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells Source: Eur Respir J 2012; 39: 446-457 Year: 2012 Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair Year: 2012 Early lung function alterations after allogeneic hematopoietic stem cell transplantation Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010 Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury Source: Eur Respir J, 59 (1) 2004216; 10.1183/13993003.04216-2020 Year: 2022 Mesenchymal stem cell based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysacharride in mice Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008 Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019 NKG2D mediated cytotoxicity towards respiratory epithelial cells suggests a mechanism for lung injury following allogeneic stem cell transplantation Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007 Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease Source: ERS Lung Science Conference 2017 Year: 2017 Fludarabine in paediatric steroid-refractory inflammatory lung injury after stem cell transplantation Source: Eur Respir J 2013; 41: 479-483 Year: 2013 Restrictive chronic lung function decline after haematopoietic stem cell transplantation Source: Eur Respir J 2016; 47: 336-339 Year: 2016 Mesenchymal stem cells prevent early inflammation in a rat model of ventilator induced lung injury Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011 Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation Source: Eur Respir J, 51 (5) 1702617; 10.1183/13993003.02617-2017 Year: 2018 Embryonic stem cell engraftment in healthy and injured mouse lung Source: Eur Respir J 2007; 30: Suppl. 51, 719s Year: 2007 Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Sarcoidosis in donor-derived tissues after haematopoietic stem cell transplantation Source: Eur Respir J 2013; 41: 1452-1453 Year: 2013